Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

The global antimetabolite drugs market is on track for steady growth, with projections indicating a compound annual growth ...

Also, Novartis AG will pay computational-chemistry expert Schrödinger Inc. $150 million up front and as much as $2.3 billion in milestones to develop several candidates along with up to $892 million ...

In May 2024, Google DeepMind released AlphaFold 3, a game changing protein folding model that predicts with 50% better ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Novartis (NVS) or Eli Lilly (LLY). But which of these two companies is the best option for those ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...

Scientists comment on the risks and benefits of tirzepatide (Mounjaro) after a UK death linked to the drug. Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University of ...

Pharmaceutical giants Novartis, AbbVie and Lilly are also part of the CIC. "We built so much enthusiasm for collaborative research and sharing ideas through virtual meetings that we wanted to keep the ...